61 In the index

Sunifiram SUNI

A very potent brain-supplement compound in rodent studies, working at surprisingly low doses. It has never been tested in human clinical trials, so its safety in people is essentially unknown despite its popularity in gray-market sales.

Also known as DM-235, Piperazine, 1-benzoyl-4-(1-oxopropyl)-, 66924E735K, 1-(4-benzoyl-1-piperazinyl)-1-Propanone, RefChem:907342, 1-(4-benzoylpiperazin-1-yl)propan-1-one, DM 235, Sunifiram DM235

Effects Focus

Routes Oral

Legal status Research chemical

WADA Not listed

3D Molecular Structure of C₁₄H₁₈N₂O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C14H18N2O2
Molar mass: 246.30
CAS: 314728-85-3
PubChem CID: 4223812
IUPAC name: 1-(4-benzoylpiperazin-1-yl)propan-1-one
InChIKey: DGOWDUFJCINDGI-UHFFFAOYSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 4-8 mg

Reported range 4-10 mg/day

Route Oral or sublingual

Frequency Once or twice daily

Duration Not established

A very potent experimental ampakine-family compound with no completed human clinical trials; nearly all data comes from rodent studies, and dosing circulating online is anecdotal, not evidence-based.

Where this comes from Animal studies only; anecdotal biohacker reports

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.